Birdwatch Note
2024-05-16 07:18:44 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
重要な背景情報として確かにこの治験では5人のワクチン接種群が死亡しましたが、プラセボ群は16人が死亡しています↓（両群の参加者はほぼ同じです) https://www.nature.com/articles/s41467-024-47905-1/tables/2 ワクチン群の1人がCOVID-19感染に関連して死亡し、プラセボ群の9人がCOVID-19感染に関連して死亡、とあります(Safety and reactogenicityとある項目の最後)。 https://www.nature.com/articles/s41467-024-47905-1 (なお参加者の17.4%は両群とも60歳以上です,表1) https://www.nature.com/articles/s41467-024-47905-1/tables/1 また確かにワクチン群は1,2,3a試験で合わせて15.2%が診療を要する有害事象を経験しましたが、22.4％のプラセボ群も期間中に経験しています↓。 https://www.nature.com/articles/s41467-024-47905-1/tables/2
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1790949544143765561
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1791005345047081270
- noteId - 1791005345047081270
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1715843924186
- tweetId - 1790949544143765561
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 重要な背景情報として確かにこの治験では5人のワクチン接種群が死亡しましたが、プラセボ群は16人が死亡しています↓（両群の参加者はほぼ同じです) https://www.nature.com/articles/s41467-024-47905-1/tables/2 ワクチン群の1人がCOVID-19感染に関連して死亡し、プラセボ群の9人がCOVID-19感染に関連して死亡、とあります(Safety and reactogenicityとある項目の最後)。 https://www.nature.com/articles/s41467-024-47905-1 (なお参加者の17.4%は両群とも60歳以上です,表1) https://www.nature.com/articles/s41467-024-47905-1/tables/1 また確かにワクチン群は1,2,3a試験で合わせて15.2%が診療を要する有害事象を経験しましたが、22.4％のプラセボ群も期間中に経験しています↓。 https://www.nature.com/articles/s41467-024-47905-1/tables/2
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-16 07:18:44 UTC (1715843924186) |
2024-05-16 12:16:15 UTC (1715861775470) |
CURRENTLY_RATED_HELPFUL | 2024-05-17 02:17:10 UTC (1715912230271) |
CURRENTLY_RATED_HELPFUL | 2024-05-16 12:16:15 UTC (1715861775470) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-16 09:55:13 -0500 | Rating Details | |
| 2024-05-16 07:23:24 -0500 | Rating Details | |
| 2024-05-16 06:55:30 -0500 | Rating Details | |
| 2024-05-16 06:34:36 -0500 | Rating Details | |
| 2024-05-16 05:56:07 -0500 | Rating Details | |
| 2024-05-16 04:46:37 -0500 | Rating Details | |
| 2024-05-16 04:32:44 -0500 | Rating Details | |
| 2024-05-16 04:29:49 -0500 | Rating Details | |
| 2024-05-16 04:26:52 -0500 | Rating Details | |
| 2024-05-16 04:18:10 -0500 | Rating Details | |
| 2024-05-16 03:43:25 -0500 | Rating Details | |
| 2024-05-16 03:33:34 -0500 | Rating Details | |
| 2024-05-16 03:31:29 -0500 | Rating Details | |
| 2024-05-16 02:52:11 -0500 | Rating Details | |
| 2024-05-16 02:46:39 -0500 | Rating Details | |
| 2024-05-16 02:35:12 -0500 | Rating Details | |
| 2024-05-16 02:35:00 -0500 | Rating Details | |
| 2024-05-16 02:27:12 -0500 | Rating Details | |
| 2024-05-16 02:21:44 -0500 | Rating Details | |
| 2024-05-17 11:07:42 -0500 | Rating Details | |
| 2024-05-16 10:32:01 -0500 | Rating Details | |
| 2024-05-16 09:34:28 -0500 | Rating Details | |
| 2024-05-16 08:34:22 -0500 | Rating Details | |
| 2024-05-16 07:59:40 -0500 | Rating Details | |
| 2024-05-16 07:45:12 -0500 | Rating Details | |
| 2024-05-16 05:20:10 -0500 | Rating Details | |
| 2024-05-16 05:18:17 -0500 | Rating Details | |
| 2024-05-16 04:38:31 -0500 | Rating Details | |
| 2024-05-16 04:19:22 -0500 | Rating Details | |
| 2024-05-16 04:19:20 -0500 | Rating Details | |
| 2024-05-16 04:15:45 -0500 | Rating Details | |
| 2024-05-16 04:12:37 -0500 | Rating Details | |
| 2024-05-16 04:07:50 -0500 | Rating Details | |
| 2024-05-16 03:53:45 -0500 | Rating Details | |
| 2024-05-16 03:26:04 -0500 | Rating Details | |
| 2024-05-16 03:25:45 -0500 | Rating Details | |
| 2024-05-16 03:16:55 -0500 | Rating Details | |
| 2024-05-16 02:52:21 -0500 | Rating Details | |
| 2024-05-16 02:46:47 -0500 | Rating Details | |
| 2024-05-16 02:43:56 -0500 | Rating Details | |
| 2024-05-16 02:38:36 -0500 | Rating Details | |
| 2024-05-16 02:26:50 -0500 | Rating Details | |
| 2024-05-16 02:19:57 -0500 | Rating Details | |
| 2024-05-18 23:43:01 -0500 | Rating Details | |
| 2024-05-18 17:31:17 -0500 | Rating Details | |
| 2024-05-17 08:20:24 -0500 | Rating Details | |
| 2024-05-17 07:52:36 -0500 | Rating Details | |
| 2024-05-16 17:28:07 -0500 | Rating Details | |
| 2024-05-16 15:47:13 -0500 | Rating Details | |
| 2024-05-16 11:53:35 -0500 | Rating Details | |
| 2024-05-16 08:27:42 -0500 | Rating Details | |
| 2024-05-16 07:13:20 -0500 | Rating Details | |
| 2024-05-16 07:00:21 -0500 | Rating Details | |
| 2024-05-16 06:13:48 -0500 | Rating Details | |
| 2024-05-16 05:20:22 -0500 | Rating Details | |
| 2024-05-16 05:04:39 -0500 | Rating Details | |
| 2024-05-16 04:33:29 -0500 | Rating Details | |
| 2024-05-16 03:33:52 -0500 | Rating Details | |
| 2024-05-16 03:13:32 -0500 | Rating Details | |
| 2024-05-16 02:37:07 -0500 | Rating Details | |
| 2024-05-16 02:31:52 -0500 | Rating Details | |
| 2024-05-16 02:30:46 -0500 | Rating Details | |
| 2024-05-24 01:41:05 -0500 | Rating Details | |
| 2024-05-17 20:07:06 -0500 | Rating Details | |
| 2024-05-17 05:10:29 -0500 | Rating Details | |
| 2024-05-16 11:54:42 -0500 | Rating Details | |
| 2024-05-16 09:14:48 -0500 | Rating Details | |
| 2024-05-16 06:42:49 -0500 | Rating Details | |
| 2024-05-16 05:33:49 -0500 | Rating Details | |
| 2024-05-16 04:58:57 -0500 | Rating Details | |
| 2024-05-16 04:55:15 -0500 | Rating Details | |
| 2024-05-16 03:26:57 -0500 | Rating Details | |
| 2024-05-16 03:05:42 -0500 | Rating Details | |
| 2024-05-16 02:45:19 -0500 | Rating Details | |
| 2024-05-16 02:32:42 -0500 | Rating Details | |
| 2024-05-16 11:16:03 -0500 | Rating Details | |
| 2024-05-17 21:59:34 -0500 | Rating Details | |
| 2024-05-16 10:47:31 -0500 | Rating Details | |
| 2024-05-16 09:55:24 -0500 | Rating Details | |
| 2024-05-16 08:41:46 -0500 | Rating Details | |
| 2024-05-16 08:08:59 -0500 | Rating Details | |
| 2024-05-16 04:41:16 -0500 | Rating Details | |
| 2024-05-16 04:29:25 -0500 | Rating Details | |
| 2024-05-16 04:05:08 -0500 | Rating Details | |
| 2024-05-16 03:56:37 -0500 | Rating Details | |
| 2024-05-16 03:37:40 -0500 | Rating Details | |
| 2024-05-16 03:35:53 -0500 | Rating Details | |
| 2024-05-16 03:28:25 -0500 | Rating Details | |
| 2024-05-16 03:24:05 -0500 | Rating Details | |
| 2024-05-16 03:07:06 -0500 | Rating Details | |
| 2024-05-16 02:58:35 -0500 | Rating Details | |
| 2024-05-16 02:28:39 -0500 | Rating Details | |
| 2024-05-16 02:23:30 -0500 | Rating Details | |
| 2024-05-16 02:23:06 -0500 | Rating Details |